These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15178713)

  • 1. Use of concomitant glycoprotein IIb/IIIa inhibitors with catheter-directed peripheral arterial thrombolysis.
    Ouriel K
    J Vasc Interv Radiol; 2004 Jun; 15(6):543-6. PubMed ID: 15178713
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of glycoprotein IIb/IIIa antagonists in peripheral arterial occlusion.
    Ouriel K
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):107-10. PubMed ID: 11981796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.
    Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
    Angiology; 2000 Nov; 51(11):913-23. PubMed ID: 11103860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.
    Ouriel K; Castaneda F; McNamara T; Swischuk J; Tepe G; Smith JJ; Clark J; Duda S
    J Vasc Interv Radiol; 2004 Mar; 15(3):229-38. PubMed ID: 15028807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of glycoprotein IIb/IIIa platelet inhibitors in peripheral vascular interventions.
    Ansel GM; George BS; Botti CF; Silver MJ
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S35-40. PubMed ID: 12439435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GP IIb/IIIa blockade during peripheral artery interventions.
    Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH
    Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPIIb-IIIa receptor inhibitors: what the interventional radiologist needs to know.
    Hofmann LV; Razavi M; Arepally A; Reginelli JP; Resar J; Geschwind JF; Corl F
    Cardiovasc Intervent Radiol; 2001; 24(6):361-7. PubMed ID: 11907740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in peripheral arterial occlusive disease.
    Jackson MR; Clagett GP
    Chest; 1998 Nov; 114(5 Suppl):666S-682S. PubMed ID: 9822070
    [No Abstract]   [Full Text] [Related]  

  • 10. Clot lysis in a primate model of peripheral arterial occlusive disease with use of systemic or intraarterial reteplase: addition of abciximab results in improved vessel reperfusion.
    Nakada MT; Montgomery MO; Nedelman MA; Guerrero JL; Cohen SA; Barnathan ES; Jordan RE
    J Vasc Interv Radiol; 2004 Feb; 15(2 Pt 1):169-76. PubMed ID: 14963184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy in peripheral vascular disease: the rationale of using both thrombolytic and antiplatelet drugs.
    Shlansky-Goldberg R
    J Am Coll Surg; 2002 Jan; 194(1 Suppl):S103-13. PubMed ID: 11800349
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Clin Geriatr Med; 2006 Feb; 22(1):57-74, viii. PubMed ID: 16377467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.
    Rebello SS; Driscoll EM; Lucchesi BR
    Stroke; 1997 Sep; 28(9):1789-96. PubMed ID: 9303027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic arterial techniques for peripheral arterial thrombolysis.
    Hoppenfeld BM; Cynamon J
    Tech Vasc Interv Radiol; 2001 Jun; 4(2):84-91. PubMed ID: 11981793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-directed thrombolysis of peripheral arterial occlusions and deep vein thrombosis.
    Kandarpa K
    Thromb Haemost; 1999 Aug; 82(2):987-96. PubMed ID: 10605814
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.
    Schweizer J; Kirch W; Koch R; Müller A; Hellner G; Forkmann L
    Angiology; 2003; 54(2):155-61. PubMed ID: 12678189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy: new dimensions 2009.
    Guha S; Mukherjee S; Hema MB
    Indian Heart J; 2009; 61(5):415-21. PubMed ID: 20635755
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of GPIIb/IIIa inhibitors in cardiovascular medicine.
    Ahrens I; Peter K; Bode C
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):233-42. PubMed ID: 15030283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
    Rukshin V; Shah PK; Cercek B; Finkelstein A; Tsang V; Kaul S
    Circulation; 2002 Apr; 105(16):1970-5. PubMed ID: 11997285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.
    Bonnard T; Tennant Z; Niego B; Kanojia R; Alt K; Jagdale S; Law LS; Rigby S; Medcalf RL; Peter K; Hagemeyer CE
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.